Panoplia Laboratories

What Panoplia Laboratories does

Active Site Research, Inc. (previously Panoplia Laboratories Inc.) is a Cambridge, MA-based 501(c)(3) non-profit research organization (EIN 93-2180352) founded in 2023 that empirically measures how frontier AI lowers barriers to biology in the physical world. Its core platform comprises two research lines: Human Studies, which conduct in-person randomized controlled trials evaluating LLM assistance on novice performance in molecular biology, and Automation, which evaluates AI agents performing complex robotics and laboratory automation tasks. Its most notable output is the largest and longest in-person randomized controlled trial in AIxBio to date, published as a mid-2025 preprint on arXiv measuring LLM assistance on novice wet-lab performance.

The organization serves three primary constituencies: researchers needing rigorous experimental validation of AI in biology, companies seeking real-world AIxBio product testing, and policymakers requiring independent evidence on frontier AI capabilities and biosecurity risk. Its underlying technology is a proprietary research methodology — including novel experimental design for in-person trials and an Automation Evaluation Framework — rather than a commercial software product. Distribution is entirely non-commercial: research outputs are released via arXiv preprints, a Substack newsletter, and a GitHub organization, with outreach through LinkedIn, X, and Bluesky.

The business model is donation-funded rather than revenue-generating. As a federally registered 501(c)(3), Active Site does not charge for its research services and accepts tax-deductible contributions (routed via every.org under the legacy 'Panoplia Laboratories Inc.' alias) to support independent biosecurity science. Reported collaborators include FMF and Sentinel Bio; named partner logos and customers are otherwise limited, and no revenue, grant totals, or donor figures are disclosed.

Name

Panoplia Laboratories

Legal name

Active Site Research, Inc.

Website

https://panoplialabs.org

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

1–10 employees

Short description

Active Site Research, Inc. is a Cambridge, MA-based 501(c)(3) non-profit that runs in-person randomized controlled trials and automation evaluations to measure how frontier AI impacts novice performance in synthetic biology, serving researchers, companies, and policymakers.

Ownership category

akta.pro rank

Product category

Biosecurity Research

NAICS

Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)

akta.pro industry

PRIMARYHLAGAJAO

AI/ML Platforms for Drug Discovery & Experiment Optimization

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

SECONDARYHLAFAMAL

Clinical Research & Trial Central Laboratories

Healthcare & Life Sciences/Healthcare Providers & Systems/Clinical Laboratories

Keywords

• Biosecurity research
• AI biology evaluation
• Wet lab automation
• Synthetic biology assessment
• AIxBio research

Headquarters

HQ city

Cambridge

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D

Distribution channels1 record

Marketing channels5 records

Core offering

Panoplia Laboratories (operating as Active Site) conducts in-person randomized controlled trials and laboratory automation evaluations to empirically measure how frontier AI systems impact novice performance in molecular biology and synthetic biology. The organization designs rigorous experiments for researchers, companies, and policymakers to resolve critical uncertainties about AI's real-world effect in wet-lab biology and biosecurity.

Product overview

Active Site Research, Inc. operates as a single unified research platform focused on measuring frontier technology in synthetic biology. The organization conducts in-person randomized controlled trials to assess how AI systems, particularly LLMs, impact novice performance in molecular biology experiments. The core research platform encompasses two primary functions: Human Studies (conducting in-person trials to measure AI impact in wet lab environments) and Automation (evaluating AI agents performing complex robotics and laboratory automation tasks). All research activities are conducted as an independent, federally registered 501(c)(3) non-profit organization.

Differentiator

Problem solved

Functional benefit

Products and services

• Active Site Research Platform A unified research platform that conducts in-person randomized controlled trials and laboratory automation evaluations to measure the real-world impact of frontier AI systems in molecular biology and synthetic biology. It serves researchers, companies, and policymakers seeking rigorous, empirical AIxBio assessment.
• Human Studies Research Service A research service conducting in-person trials to measure the impact of frontier AI on novice performance in wet lab molecular biology environments. Designed for researchers, companies, and policymakers who need empirical data on how AI lowers barriers to biology in the physical world.
• Automation Evaluation Service A research service that evaluates AI agents performing complex robotics and laboratory automation tasks, providing independent assessment of AI agent capabilities in synthetic biology settings.

Quantifiable outcome

• Largest and longest in-person randomized controlled trial in AIxBio conducted in Mid-2025 measuring LLM-Assistance on novice performance in biology

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Two partnerships are on record, tiered minor.

• FMF LogominorStrategic or Co-development PartnerFMF Logo appears as a collaborator organization listed under the 'WE HAVE WORKED WITH' section on the Active Site website, indicating a working relationship in research or advisory capacity.
• Sentinel BiominorStrategic or Co-development PartnerSentinel Bio appears as a collaborator organization listed under the 'WE HAVE WORKED WITH' section on the Active Site website, indicating a working relationship in synthetic biology research.

Recent moves6 records

Expansion highlights5 records

Emerging players

• Redwood Research: An AI safety research non-profit working on alignment and risk evaluation of frontier AI systems. Comparable as a research-oriented safety non-profit, though Redwood's work is more theoretical/alignment-focused while Active Site does empirical wet-lab experimentation.
• Conjecture: An AI safety company building empirical evaluations and technical alignment work for frontier models. Comparable as an evaluator of frontier AI capabilities, though operating as a commercial entity rather than a non-profit.
• GovAI: A research organization producing rigorous analysis on AI governance and frontier AI policy. Comparable as a research-output-driven organization feeding evidence into policymakers, with overlapping customer segment (policymakers) but more policy-analysis oriented than Active Site's experimental work.
• Epoch AI: A research institute focused on tracking and forecasting AI capability progress with rigorous empirical methods. Comparable as a research-oriented non-profit producing empirical evidence on frontier AI for policymakers, though focused on macro-trend data rather than wet-lab RCTs.

Direct peers

• METR (Model Evaluation and Threat Research): An AI safety non-profit that designs rigorous empirical evaluations of frontier AI capabilities, including agentic and autonomous task performance. Highly comparable to Active Site's mission of producing evidence-based assessments of AI capabilities, though METR's scope is broader (cyber, reasoning, agentic) while Active Site focuses on wet-lab biology.
• SecureBio: A non-profit focused on reducing biorisk from emerging technologies, including evaluating how AI lowers barriers to biological capabilities. Direct overlap with Active Site's AIxBio evaluation mandate and shares the same independent-research, biosecurity-policy customer base.
• Apollo Research: An AI safety research organization focused on evaluating frontier models for dangerous capabilities, deception, and autonomy. Comparable as an independent evaluator producing empirical evidence on AI risks, though focused on model behavior rather than wet-lab task performance.

Broad incumbents

• RAND Corporation: A large, established research institution producing policy-relevant empirical analyses across many domains including biosecurity. Comparable as a trusted, independent research output feeding policymakers; much broader scope but overlapping customer segment.
• Future of Life Institute: A large, well-funded non-profit working on AI governance, biosecurity, and catastrophic risk policy. Comparable as an independent voice producing evidence for AI policy, with broader scope than Active Site; one of the likely funder types in the AI biosecurity evaluation space.

Regional players

• Innovative Genomics Institute: A scientific research institute applying cutting-edge genomic and biotechnology tools with embedded biosecurity considerations. Comparable as a research organization operating at the intersection of frontier biology and societal risk, though focused on the science itself rather than AI-impact evaluation.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/ActiveSiteBio
• GitHubgithub.com/ActiveSiteBio
• LinkedInlinkedin.com/company/panlabs

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Panoplia Laboratories